Assessing the evidence that antibiotic growth promoters influence human infections.
Phillips
I
I
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D004352:Drug Resistance, Microbial; D016984:Enterococcus faecium / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology*; D006133:Growth Substances / Q000009:adverse effects*; D006801:Humans; D012307:Risk Factors; D014769:Virginiamycin / Q000009:adverse effects* / Q000037:antagonists & inhibitors
D000900:Anti-Bacterial Agents; D006133:Growth Substances; D014769:Virginiamycin